Bristol-Myers Squibb Company (BMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,911,000 | 5,421,000 | 4,237,000 | 2,385,000 | 5,571,000 |
| Marketable Securities | 1,848,000 | 1,391,000 | 2,113,000 | 1,885,000 | 1,864,000 |
| Receivables | 5,747,000 | 6,300,000 | 5,543,000 | 4,299,000 | 3,390,000 |
| Inventories | 1,195,000 | 1,166,000 | 1,241,000 | 1,221,000 | 1,560,000 |
| Income taxes - deferred | N/A | N/A | N/A | N/A | 1,644,000 |
| Other current assets | 2,015,000 | 0 | 0 | 0 | 109,000 |
| TOTAL | $17,716,000 | $14,854,000 | $13,704,000 | $10,415,000 | $14,608,000 |
| Non-Current Assets | |||||
| PPE Net | 5,027,000 | 5,001,000 | 4,980,000 | 4,412,000 | 4,417,000 |
| Investments And Advances | 1,775,000 | 2,480,000 | 2,719,000 | 4,660,000 | 4,408,000 |
| Intangibles | 7,629,000 | 8,073,000 | 8,260,000 | 8,300,000 | 8,780,000 |
| Other Non-Current Assets | 2,839,000 | 3,143,000 | 4,044,000 | 3,961,000 | 1,536,000 |
| TOTAL | $17,270,000 | $18,697,000 | $20,003,000 | $21,333,000 | $19,141,000 |
| Total Assets | $34,986,000 | $33,551,000 | $33,707,000 | $31,748,000 | $33,749,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,703,000 | 987,000 | 992,000 | 139,000 | 590,000 |
| Accounts payable and accrued liabilities | 1,892,000 | 2,248,000 | 1,664,000 | 1,565,000 | 2,487,000 |
| Accrued Expenses | N/A | N/A | N/A | N/A | 2,459,000 |
| Other current liabilities | 7,059,000 | N/A | N/A | N/A | N/A |
| TOTAL | $10,654,000 | $9,563,000 | $8,841,000 | $8,017,000 | $8,461,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 5,646,000 | 6,975,000 | 5,716,000 | 6,550,000 | 7,242,000 |
| Deferred Revenues | N/A | 83,000 | 762,000 | 1,003,000 | 1,167,000 |
| aiOther Non-Current Liabilities | 4,513,000 | 1,196,000 | 1,233,000 | 1,363,000 | 1,708,000 |
| TOTAL | $10,205,000 | $12,141,000 | $8,519,000 | $9,307,000 | $10,305,000 |
| Total Liabilities | $20,859,000 | $21,704,000 | $17,360,000 | $17,324,000 | $18,766,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,632,676 | 1,632,583 | 1,672,715 | 1,669,459 | 1,662,118 |
| Common Shares | 221,000 | 221,000 | 221,000 | 221,000 | 221,000 |
| Retained earnings | 34,065,000 | 31,160,000 | 33,513,000 | 31,613,000 | 32,541,000 |
| Other shareholders' equity | -2,666,000 | -2,183,000 | -2,333,000 | -2,310,000 | -2,294,000 |
| TOTAL | $14,127,000 | $11,847,000 | $16,347,000 | $14,424,000 | $14,983,000 |
| Total Liabilities And Equity | $34,986,000 | $33,551,000 | $33,707,000 | $31,748,000 | $33,749,000 |